These newborn patients are more likely to develop hypoalbuminemia, with many possibilities to use drugs that alter albumin binding (e.g., antimicrobial drugs, fat formulations, and indomethacin), which consequently affect bilirubin binding to albumin to result in hyper-unbound bilirubinemia [1]. The gene discussed is ALB; the disease is Hypoalbuminemia.